Who is sponsoring NCT07300852?

NCT07300852 is sponsored by Ngoc Nguyen Inc..

What drugs are being tested in NCT07300852?

Interventions in NCT07300852: Direct Selective Laser Trabeculoplasty (DSLT).

What condition does NCT07300852 study?

NCT07300852 studies Normal Tension Glaucoma (NTG), Glaucoma, Open Angle Glaucoma (OAG), Glaucoma, Open Angle.

Is NCT07300852 still recruiting?

NCT07300852 is currently not yet recruiting. Last updated 24 December 2025.

Last reviewed 2025-12-24 · How we verify

NCT07300852

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DSLT in Normal Tension Glaucoma (NTG) Asian Eyes

Not yet recruiting NA Last updated 24 December 2025

What this trial tests

NA trial testing Direct Selective Laser Trabeculoplasty (DSLT) in Normal Tension Glaucoma (NTG) in 40 participants. Not yet recruiting.

Timeline

1 January 2026

Primary endpoint
31 January 2028

31 March 2028

Quick facts

Lead sponsor	Ngoc Nguyen Inc.
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 January 2026
Primary completion	31 January 2028
Estimated completion	31 March 2028
Sites	1 location across United States

Drugs / interventions tested

Direct Selective Laser Trabeculoplasty (DSLT)

Conditions studied

Normal Tension Glaucoma (NTG) — all drugs for Normal Tension Glaucoma (NTG) →
Glaucoma — all drugs for Glaucoma →
Open Angle Glaucoma (OAG) — all drugs for Open Angle Glaucoma (OAG) →
Glaucoma, Open Angle — all drugs for Glaucoma, Open Angle →

Sponsor

Ngoc Nguyen Inc.

Who can join

20 and older, any sex, with Normal Tension Glaucoma (NTG) or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the efficacy of direct selective laser trabeculoplasty (DSLT) or laser treatment in Asian patients with normal tension glaucoma. The main question it aims to answer is: Does the DSLT reduce intraocular pressure (IOP) and medication use in Asian NTG subjects? Participants will attend routine follow-up visits with their eye surgeon and glaucoma testing such as optical coherence tomography (OCT) imaging and visual field test(s) after the laser study treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Direct Selective Laser Trabeculoplasty (DSLT)

Trials testing the same drug.

NCT04758598 — The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07300852 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ngoc Nguyen Inc.
Last refreshed: 24 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07300852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing